Long-Term Impacts of Orthokeratology Treatment on Sub-Basal Nerve Plexus and Corneal Sensitivity Responses and Their Reversibility by Nombela Palomo, María et al.
Eye & Contact Lens
 
Long-term impacts of OK treatment on sub-basal nerve plexus and corneal sensitivity
responses and their reversibility
--Manuscript Draft--
 
Manuscript Number: ECL-16-173R3
Full Title: Long-term impacts of OK treatment on sub-basal nerve plexus and corneal sensitivity
responses and their reversibility
Article Type: Original Study
Keywords: sub-basal nerve plexus, corneal sensitivity, overnight orthokeratology, density,
tortuosity.
Corresponding Author: Maria Nombela-Palomo
Universidad Complutense de Madrid
Madrid, SPAIN
Corresponding Author Secondary
Information:
Corresponding Author's Institution: Universidad Complutense de Madrid
Corresponding Author's Secondary
Institution:
First Author: Maria Nombela-Palomo
First Author Secondary Information:
Order of Authors: Maria Nombela-Palomo
Gema Felipe-Marquez
Miguel Teus
Jose Luis Hernandez-Verdejo
Amelia Nieto-Bona
Order of Authors Secondary Information:
Abstract: PURPOSE: To examine the effects of 1 year of overnight orthokeratology (OK)
treatment on the sub-basal nerve plexus (SBNP) and corneal sensitivity and to assess
the reversibility of these effects 1 month after treatment interruption.
METHODS: 32 subjects with low-moderate myopia underwent OK treatment for one
year. 15 non-contact lens wearers served as controls.  At the time points baseline, 1
year of treatment, and 1 month after removing the OK lenses, two tests were
conducted: corneal sensitivity (Cochet-Bonnet esthesiometer) and SBNP imaging by in
vivo confocal microscopy.
RESULTS: In participants wearing OK lenses, significant reductions over the year were
produced in SBNP nerve density (p=0.001 and p=0.006) and number of nerves
(p<0.001 and p=0.001) in the central and mid-peripheral cornea respectively.
Differences over the year were also detected in central objective tortuosity (p=0.002).
Following lens removal, baseline values of nerve density (p=0.024 and p=0.001) and
number of nerves (p=0.021 and p<0.001) for the central and mid-peripheral cornea
respectively were not recovered. At 1 month post-treatment, a difference was observed
from 1 year values in central corneal sensitivity (p=0.045) and mid-peripheral
Langerhans cell density (p=0.033), and from baseline in mid-peripheral objective
tortuosity (p=0.049). Direct correlation was detected at 1 year between nerve density
and tortuosity both in the central (p<0.01; r= 0.69) and mid-peripheral cornea (p<0.01;
r= 0.76).
CONCLUSIONS: Long term OK treatment led to reduced SBNP nerve density and this
was directly correlated with corneal tortuosity. After 1 month of treatment interruption,
nerve density was still reduced.
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ABSTRACT  41 
PURPOSE: To examine the effects of 1 year of overnight orthokeratology (OK) treatment on 42 
the sub-basal nerve plexus (SBNP) and corneal sensitivity and to assess the reversibility of 43 
these effects 1 month after treatment interruption.   44 
 45 
METHODS: 32 subjects with low-moderate myopia underwent OK treatment for one year. 15 46 
non-contact lens wearers served as controls.  At the time points baseline, 1 year of treatment, 47 
and 1 month after removing the OK lenses, two tests were conducted: corneal sensitivity 48 
(Cochet-Bonnet esthesiometer) and SBNP imaging by in vivo confocal microscopy.   49 
 50 
RESULTS: In participants wearing OK lenses, significant reductions over the year were 51 
produced in SBNP nerve density (p=0.001 and p=0.006) and number of nerves (p<0.001 and 52 
p=0.001) in the central and mid-peripheral cornea respectively. Differences over the year 53 
were also detected in central objective tortuosity (p=0.002). Following lens removal, baseline 54 
values of nerve density (p=0.024 and p=0.001) and number of nerves (p=0.021 and p<0.001) 55 
for the central and mid-peripheral cornea respectively were not recovered. At 1 month post-56 
treatment, a difference was observed from 1 year values in central corneal sensitivity 57 
(p=0.045) and mid-peripheral Langerhans cell density (p=0.033), and from baseline in mid-58 
peripheral objective tortuosity (p=0.049). Direct correlation was detected at 1 year between 59 
nerve density and tortuosity both in the central (p<0.01; r= 0.69) and mid-peripheral cornea 60 
(p<0.01; r= 0.76). 61 
 62 
CONCLUSIONS: Long term OK treatment led to reduced SBNP nerve density and this was 63 
directly correlated with corneal tortuosity. After 1 month of treatment interruption, nerve 64 
density was still reduced.  65 
 66 
KEYWORDS: sub-basal nerve plexus, corneal sensitivity, overnight orthokeratology, density, 67 
tortuosity.  68 
69 
INTRODUCTION 70 
The cornea is the most densely innervated tissue in the human body. Its morphological 71 
changes in response to factors such as ageing, disease or surgery have been widely studied 72 
ex-vivo1-5 and in-vivo6-10.  The methods used to detect these changes have been traditionally 73 
electron and light microscopy. However, the more recently introduced in vivo confocal 74 
microscopy (IVCM) has proved especially useful for this purpose11 due to its non-invasive 75 
nature.  This has resulted in significant progress in the in vivo study of corneal morphological 76 
changes, with special emphasis placed on the epithelium and sub-basal nerve plexus (SBNP). 77 
Using this technology, it has being possible to assess these changes in the corneas of 78 
healthy individuals10, soft contact lens wearers7,8, subjects undergoing corneal surgery12,13, 79 
patients with a systemic diseass14,15 and those undergoing overnight orthokeratology (OK) 80 
treatment9,16,17.  81 
In a clinical trial conducted in 2011 in patients who wore OK lenses daily for a whole year9,  82 
Nieto-Bona et al noted structural changes in the cornea, though warned that their data 83 
needed confirming in a larger study. More recently, another research group conducted a 84 
study16 which revealed that wearing OK lenses modifies the normal pattern of SBNP nerve 85 
distribution. Additionally, OK lenses have been reported to compromise corneal nerve 86 
function18. This latter effect can be assessed through corneal sensitivity testing. Several 87 
authors have addressed correlation between corneal architecture and corneal sensitivity12-15,19. 88 
Patel et al8 correlated SBNP nerve density, SBNP nerve tortuosity and corneal sensitivity in a 89 
large population of non-contact lens wearers. More recently, Lum et al reported a reduction in 90 
corneal sensitivity and SBNP nerve density over both short-term20 and long-term21 periods of 91 
OK lens wear. However, correlations between SBNP nerve density, nerve tortuosity and 92 
corneal sensitivity have not yet been detected in the healthy corneas of OK users in the long 93 
term.  94 
SBNP nerve redistribution has been linked to increased levels of pro-inflammatory 95 
molecules22. Consequently, and bearing in mind that inflammation due to the use of contact 96 
lenses induces the migration of Langerhans cells (LC) to the cornea23,24, we recently 97 
performed a study17 in which it was observed that the use of OK lenses over a short period 98 
increases LC density in the cornea. However, little is still known about the course of these 99 
changes in the longer term and their possible recovery after interrupting OK lens wear. 100 
The present study was designed to objectively and prospectively analyze the changes 101 
produced in LC density and SBNP morphology and their correlation with corneal sensitivity in 102 
a large population of subjects undergoing OK treatment for 1 year. The reversibility of these 103 
responses after discontinuing treatment was also assessed. Based on the recent finding of 104 
different short term responses to different OK lenses17, two different OK lens designs were 105 
fitted in our participants. SBNP thickness changes were also examined. Our working 106 
hypothesis was that over a long term period, OK lenses will produce morphological changes 107 
in the corneal SBNP layer with repercussions on central and mid-peripheral corneal sensitivity.  108 
METHODOLOGY 109 
This was a prospective, longitudinal, single-center study of 13 months' duration. The study 110 
protocol was approved by the Ethics Committee of the Hospital Clinico San Carlos and 111 
adhered to the tenets of the Declaration of Helsinki. The follow up times established were 112 
baseline, 1 year and 13 months, when corneal morphology and corneal sensitivity were 113 
determined in patients undergoing 1 year of OK treatment with two different types of OK 114 
lenses.  As a control group, non contact lens wearers were also examined at the three time 115 
points. 116 
Sample size calculation 117 
Based on the mean SBNP nerve densities observed in prior work17 (n=71, 10687 ± 5046 118 
µm/mm2), we calculated the sample size required for this study using Granmo 7.12 software. 119 
For an alpha risk of 0.05 and a beta risk of 0.2 in a 2-tailed test, it was calculated that 28 120 
subjects would be needed in the treatment group and 14 in the control group to detect a 121 
significant difference equal or greater than 3200 µm/mm2 and a correlation coefficient 122 
between the initial and final measurement of 0.8. The dropout rate anticipated was of 15%.   123 
Subjects 124 
Participants were subjects from our previous study who were offered the possibility of 125 
continuing OK treatment for this stage of the study. Written consent was obtained from 126 
participants after the nature and possible consequences of the study had been explained to 127 
them. Subjects contacted the research group via the free access website 128 
http://www.ucm.es/accion-social.  129 
In a preliminary interview and tests, it was determined whether subjects met the following 130 
inclusion criteria: age 18 to 30 years old, refractive status -0.50 to -5.00 DS and -0.25 to -1.25 131 
DC, no systemic or eye disease, no history of eye surgery, and no evidence of keratoconus or 132 
corneal irregularity. Rigid gas permeable contact lens (CL) wearers were excluded from the 133 
study. Hydrophilic CL users were instructed to remove their lenses four weeks before starting 134 
the study. Pregnant women and those planning to become pregnant during the study were 135 
also excluded.  136 
The subjects enrolled were randomly assigned to 2 groups: a control group comprised of 20 137 
individuals who wore no contact lenses, and a treatment group comprised of 20 subjects 138 
(subgroup CRT) who wore HDS 100 Paragon CRT lenses (Paragon Vision Sciences; 139 
Interlenco, Madrid, Spain) and 20 subjects (subgroup SF) who wore Seefree® lenses made 140 
of Boston XO2 material (Conóptica, Barcelona, Spain) in both eyes. After enrolment, 13 141 
participants withdrew from the study: three in the CRT subgroup, two in the SF subgroup and 142 
three in the control group because they did not keep all the follow-up appointments and three 143 
in the SF subgroup and two in the control group because they moved away from Madrid. This 144 
left a study population of 47 subjects: 15 in the control group and 32 in the treatment group 145 
(17 in CRT and 15 in SF). 146 
Tests 147 
At each follow up time (baseline, 1 year, 13 months), corneal sensitivity was measured using 148 
a Cochet-Bonnet esthesiometer (Luneau, Paris, France) and corneal morphology was 149 
examined by IVCM using a corneal module (Heidelberg Retina Tomograph II [HRT], Rostock 150 
Corneal Module [RCM]; Heidelberg Engineering GmbH, Heidelberg, Germany). Image 151 
acquisition and image analysis of the SBNP was conducted followed the procedure outlined 152 
in a previous study17. This involved a masked-fashion analysis of the best-focused image of 153 
each set of images with three different software packages: ImageJ (http: www. 154 
rsb.info.nih.gov/ij), NeuronJ (http: imagescience.org/meijering/software/neuronj/) and Matlab 155 
(MatLab; The Mathworks, Natick, MA). Each package was used for different SBNP variables: 156 
ImageJ for SBNP thickness, global and local reflectivity, width, orientation, length and density 157 
of nerves as well as the number of Langerhans cells; NeuronJ for nerve reflectivity and 158 
number of nerves; and Matlab for nerve tortuosity.  All tests were conducted in the right eye 159 
by a single experienced clinician within 2 to 4 h of OK lens removal. Besides the three 160 
planned visits, patients were required to attend all the standard visits for OK lens fitting and 161 
fluorescein staining to assess ocular surface health at each visit. These clinical procedures 162 
have been formerly described elsewhere25.  163 
Statistical analysis  164 
Data were recorded in Excel (2003, Microsoft) and analyzed using SigmaPlot version 12 165 
(Systat Software Inc.). Statistical analysis was performed on the data obtained for the right 166 
eye of each subject. We checked the distribution of data using the Kolmogorov-Smirnov 167 
normality test. To analyze changes over time in each group, we used one-way repeated 168 
measures analysis of variance (ANOVA) and the post-hoc paired t-test according to the 169 
distribution of data with Bonferroni correction for multiple comparisons. For variables that 170 
changed significantly over time, we searched for correlations among them through simple 171 
regression analyses and also compared the two OK treatment subgroups for these variables 172 
by 2-way analysis of variance (group x time) and conducted post-hoc paired tests with 173 
Bonferroni correction. All data are reported as the mean ± standard deviation (SD).  174 
Significance was set at p<0.05. 175 
RESULTS 176 
The final study sample was made up of 47 subjects, 25 male and 22 female, of mean age ± 177 
SD 25.1 ± 3.7 years. The treatment group (subgroups CRT and SF) included 32 healthy right 178 
eyes. None of the OK lens wearers who completed the treatment protocol reported adverse 179 
effects related to lens wear, and no eye abnormalities were detected on slit-lamp microscopy. 180 
As may be seen in Table 1, the treatment and control groups were well matched in terms of 181 
subject numbers, age and refractive and keratometry measurements.  182 
Baseline values for SBNP variables measured in the central cornea in the control group are 183 
shown in Table 4. As may be seen, none of these variables showed a significant difference 184 
over time. Mid-peripheral data could not be obtained in the control group since best-focused 185 
SBNP images were insufficiently clear. Thus, only corneal sensitivity (4.98 ± 0.52 cm) and 186 
SBNP thickness data (11.41 ± 1.27 m) were available for the mid-peripheral cornea in the 187 
control group. Data for the control group at the 1-month post-treatment visit are not shown in 188 
the tables because almost 75% of the subjects did not attend this visit such that we had 189 
insufficient data for this time point. 190 
Post-hoc comparisons of means indicated no differences over time in neither the central nor 191 
mid-peripheral cornea for almost all variables as p > 0.05 for each pair of data (baseline vs 1 192 
year). The central and mid-peripheral corneal variables recorded in the treatment group are 193 
provided in Tables 2 and 3 respectively. Statistical analysis revealed almost no differences 194 
over time for many of the variables considered in the treatment group. However, some 195 
significant changes over the study period were produced in the factors central and mid-196 
peripheral number of nerves, nerve density and objective tortuosity, central corneal sensitivity 197 
and mid-peripheral number of Langerhans cells. Number of nerves fell significantly in the 198 
central (p<0.001) and mid-peripheral cornea (p=0.001) from baseline to 1 year and thereafter 199 
remained stable after 1 month of lens removal (p=0.18 central cornea, p=0.11 mid-peripheral 200 
cornea). Nerve density also fell over the year in the central (p=0.001) and mid-peripheral 201 
(p=0.006) cornea and remained stable after lens removal (p=0.51 central cornea, p=0.43 mid-202 
peripheral cornea). Central objective tortuosity also fell significantly over the year (p=0.002) 203 
while mid-peripheral objective tortuosity was reduced 1 month after lens removal (p=0.049). 204 
Central corneal sensitivity improved significantly from 1 year to 1 month post treatment 205 
(p=0.045) and number of Langerhans cells in the mid-peripheral cornea decreased between 206 
these two time points (p=0.033).  207 
No correlation was detected between nerve density and corneal sensitivity (p= 0.24; r= -0.24) 208 
in the central cornea and between nerve density and LC density (p= 0.34; r =0.19) in the mid-209 
peripheral cornea. However, we did find direct correlation between nerve density and 210 
tortuosity both in the central (p<0.01; r= 0.69) and mid-peripheral (p<0.01; r= 0.76) cornea 211 
after 1 year of treatment. 212 
Graphs were prepared to compare the trends produced in the variables varying significantly 213 
over time in the CRT and SF subgroups. These variables showed similar trends over time 214 
(Fig 1a-1f). By 2-way ANOVA, we calculated the statistical power of any differences detected 215 
between the two OK treatment subgroups. With the exception of central corneal sensitivity, 216 
power values revealed similar trends in the variables measured over the year: central corneal 217 
sensitivity β=0.27, central nerve density β=0.17, central objective tortuosity β=0.04, mid-218 
peripheral Langerhans cell density β=0.05, mid-peripheral nerve density β=0.12 and mid-219 
peripheral objective tortuosity β=0.10. 220 
 221 
DISCUSSION 222 
This study was designed to examine the SBNP in detail and to assess the changes produced 223 
in several of its parameters during the prolonged use of OK lenses and after one month of 224 
their discontinued use. Baseline data for SBNP thickness and the remaining variables 225 
examined were consistent with the ranges reported for normal corneas7-9,19. All the nerve 226 
morphology variables that showed some variation over the year of treatment returned to 227 
baseline after treatment was interrupted with the exception of central and mid-peripheral 228 
SBNP nerve density and number of nerves. 229 
Corneal sensitivity values were within expected normality values in each study visit. However, 230 
they were slightly lower than those reported for hydrophilic CL wearers19 and normal 231 
corneas18,26. No control-treatment group differences were observed at baseline. Surprisingly, 232 
our findings showed stable corneal sensitivity values from baseline to 1 year of OK treatment. 233 
This is in conflict with the reduction in corneal sensitivity observed after 1 month17 and 3 234 
months20 of OK lens wear. A possible explanation for the stabilization of the corneal 235 
sensitivity after 1 year of OK treatment could be neural adaptation to the pressure exerted by 236 
the lens described by Draeger27. We propose that this neural adaptation could have occurred 237 
somehow between three months and one year of treatment. Further study would be needed 238 
to confirm this theory. In line with this idea, other authors20 have noted the recovery of corneal 239 
sensitivity 3 months after the removal of OK lenses. This finding is consistent with our 240 
observations, given the significant increase in central corneal sensitivity observed between 1 241 
year of treatment and 1 month post-treatment (p=0.045). In the CRT subgroup we observed a 242 
similar decreasing trend in this variable followed by an increasing trend one month after lens 243 
removal. In contrast, no mid-peripheral changes were observed. This finding is in line with 244 
previous results in OK wearers20,28 in studies in which it was speculated that changes in 245 
corneal sensitivity would be limited to the central cornea while the peripheral cornea would be 246 
unaffected.  247 
The variables SBNP nerve density and number of nerves are closely linked. As expected both 248 
experienced changes during the course of OK treatment. Our nerve density values are lower 249 
than those reported for subjects with healthy corneas8 and OK lens wearers21. This difference 250 
may be attributed to the fact that we only considered the main nerves detected in the best-251 
focused image while others have included all nerve branches. It should also be considered 252 
that the present study participants were healthy subjects tested after 1 year of OK lens wear.  253 
Recently Lum et al21 noted a reduction in nerve fiber density in response to 3 months of OK; 254 
with respect to controls, this reduction was of around 31%. In 2010, Nieto-Bona observed 255 
following 3 months of OK lens wear changes including effects on the SBNP29. In the present 256 
study, a 42% reduction in nerve density was produced from baseline to 1 year post OK 257 
treatment. In the central cornea, both nerve density and nerve fiber numbers significantly fell 258 
over the year (p=0.001 and p<0.001 respectively), consistent with the central nerve loss 259 
reported by Lum et al16,21. Nieto-Bona et al9 also noted a decreasing trend in nerve density 260 
using the same procedure to assess this variable, though we also used a semi-automated 261 
tool (NeuronJ) for this purpose. In our study, one month after discontinuing the use of OK 262 
lenses, nerve density values were still diminished compared to baseline (p=0.024 and 263 
p=0.021 respectively). In line with this result and given previous descriptions of the 264 
redistribution of nerve fibers towards the periphery16, the decrease in nerve density (p=0.006) 265 
and nerve number (p=0.001) detected here in the corneal periphery after one year of 266 
treatment is surprising. A possible explanation is that we took these measurements in a more 267 
peripheral zone possibly explaining the discrepancy with other observations16. In effect, our 268 
target location for nerve measurements was 4 mm infero-temporal and thus it is possible that 269 
our mid-peripheral data are representative of the corneal region beneath the landing zone 270 
rather than the optic or return zone area of the OK lens. This could possibly explain the 271 
reduced nerve density observed mid-peripherally following treatment. The fact that both 272 
variables did not return to baseline values (p=0.001 and p<0.001 respectively) is consistent 273 
with the non-significant trend reported by Nieto-Bona29. Our comparison of nerve density 274 
between the two treatment subgroups revealed the similar behavior of this factor at both 275 
locations (Fig.1b and Fig.1e). In addition, the fact that nerve density did not increase in the 276 
mid-periphery (Fig.1e), as expected according to prior findings16, could be caused by the 277 
proximity of the measurement zone to the return zone17. In future work, it would be interesting 278 
to assess a more peripheral zone of the cornea at a later time point following OK lens 279 
discontinuation.   280 
To date, it has been established that nerve tortuosity increases with the severity of a 281 
neuropathy30 and with age8. Notwithstanding, in the present study, objective tortuosity was 282 
assessed in healthy young OK wearers. Despite baseline values being in agreement with 283 
reported values8,30, after one year of study, a significant reduction in objective tortuosity was 284 
produced (p=0.002). In the mid-peripheral cornea, reduced tortuosity was observed in the 1 285 
month post treatment visit (p=0.049). This finding is consistent with the reduced nerve density 286 
observed at this recovery time point. Further, our linear regression values indicate direct 287 
correlation between nerve density and tortuosity in both the central (p<0.01; r= 0.69) and 288 
peripheral (p<0.01; r= 0.76) cornea. This correlation has been addressed by others in healthy 289 
corneas, and weak correlation was observed in the inferior and nasal cornea regions at a 290 
single time point 8. Lum et al16, in contrast, observed a tortuous network of less dense nerve 291 
fibers, though these authors examined only two long term OK lens wearers and assessed a 292 
much larger area than in our study.  293 
The immunological functions of dendritic cells and their role in corneal inflammation and dry 294 
eye have been well defined31,32. Accordingly, it may be assumed that the cornea will respond 295 
to contact lenses as it would to a foreign body by increasing the density of Langerhans cells. 296 
This response is triggered by the mechanical irritation and hypoxia associated with lens wear. 297 
We observed a clear trend for LC density to increase in the mid-peripheral cornea following 298 
one year of OK lens wear. Notwithstanding, the only significant change noted was the 299 
decrease of this variable (p=0.033), a behavior that has not been detected in prior work17.  300 
In conclusion, our findings indicate a significant reduction in the nerve density of the sub-301 
basal plexus in response to one year of OK treatment that was not associated with changes 302 
in corneal sensitivity but was linked to changes in nerve tortuosity both in the central and 303 
peripheral cornea. This effect was not reversed one month after treatment interruption neither 304 
in the central nor mid-peripheral cornea, suggesting a longer period of non OK lens wear 305 
would be needed to recover baseline values. In contrast, in this same 1 month period, corneal 306 
sensitivity was higher after lens removal. This determines that 1 month after OK lens 307 
discontinuation, there is a reduction in nerve density 4 mm from the corneal apex that do not 308 
correlate with our corneal sensitivity findings. According to our 2-way ANOVA and post-hoc 309 
statistical power calculations, the two OK lenses used showed similar effects on SBNP 310 
morphology. Although the corneal zone observed by IVCM was smaller than that examined 311 
by others8,16, our large sample size provides sufficient evidence of these changes. In future 312 
studies, these findings should be confirmed by examining a larger area over a longer 313 
recovery period.      314 
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Table 1. Refractive and corneal variables recorded at baseline prior to OK treatment. n number of subjects, m mean, 411 
SD standard deviation, Sim Kflat and Sim Ksteep simulated keratometry readings along the flatter and steeper 412 
meridians. 413 
 414 
Table 2. Variables recorded at baseline prior to OK treatment and changes produced in the central cornea after 1 415 
year of continuous OK treatment and 1 month after removing lenses. n number of right eyes of subjects/ number of 416 
items, m mean, SD standard deviation, cm centimeters, _m microns, mm2 squared millimeters, ND nerve density, 417 
LCD Langerhans cells density, STC subjective tortuosity coefficient, OTC objective tortuosity coefficient. (†) indicates 418 
significant differences between values at baseline and 1 year at p<0.01; (*) indicates significant differences between 419 
values at baseline and 1 month post-treatment at p<0.05. (_) indicates significant differences between values at 1 420 
year of treatment and at 1 month post-treatment at p<0.05. 421 
 422 
Table 3. Variables recorded at baseline prior to OK treatment and changes produced in the mid-peripheral cornea 423 
after 1 year of continuous OK treatment and 1 month after removing lenses. n number of right eyes of subjects/ 424 
number of items, m mean, SD standard deviation, cm centimeters, _m microns, mm2 squared millimeters, ND nerve 425 
density, LCD Langerhans cells density, STC subjective tortuosity coefficient, OTC objective tortuosity coefficient. (†) 426 
indicates significant differences between values at baseline and 1 year, p<0.01; (*) indicates significant differences 427 
between values at baseline and 1 month post-treatment at p<0.05; (‡) indicates significant differences between 428 
values at baseline and 1 month post-treatment at p<0.01, (_) indicates significant differences between values at 1 429 
year of treatment and at 1 month post-treatment at p<0.05. 430 
 431 
Table 4. Parameter values for the control group and changes produced over 1 year. Positive values shown in the ∆ 432 
column correspond to a rise in the parameter value. n number of subjects/items, m mean, SD standard deviation, _ 433 
difference between values at baseline and in the 1 year visit, cm centimeters, _m microns, mm2 squared millimeters. 434 
 435 
Figure 1. Two-way ANOVA (subgroup x time). Graphs a to f display the means (shown on y-axis) of the variables 436 
quantified objectively in the subgroups CRT and SF (0 = baseline, 1 = after 1 year of OK treatment and 2 = 1 month 437 
post-treatment) in the central (a-c) and mid-peripheral (d-f) cornea. pv is the value of p for the variable time point; pg 438 
is the value of p for the variable subgroup; pvxg is the value of p for the product of the variables time point and 439 
subgroup. 440 
Table 1 
 
Control group 
(n=15) 
 
Treatment group  
(n=32) 
 
Unpaired 
t-test 
 m ± SD 
 
Male/Female (n) 
 
9/6 
 
16/16 
 
 
 
Age (years) 25.6 ± 3.3 24.86 ± 3.92 p=0.53 
Sphere (D) -2.89 ± 1.30 -2.40 ± 0.96 p=0.14 
Cylinder (D) -0.31 ± 0.41 -0.17 ± 0.27 p=0.17 
Sim Kflat (D) 43.03 ± 1.95 43.32 ± 1.40 p=0.56 
Sim Ksteep (D) 43.63 ± 1.76 44.02 ± 1.49 p=0.43 
 
Table 1. Refractive and corneal variables recorded at baseline prior to OK treatment. n number of subjects, m mean, 
SD standard deviation, Sim Kflat and Sim Ksteep simulated keratometry readings along the flatter and steeper 
meridians. 
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TABLE 2 
CENTRAL  
(n = 32) 
 
BASELINE 
(m ± SD) 
 
TREATMENT  
1 YEAR   
(m ± SD) 
 
1 MONTH POST-
TREATMENT 
(m ± SD) 
 
ANOVA 
p-value 
Corneal sensitivity (cm) 5.28 ± 0.66 5.27 ± 0.54 5.67 ± 0.29 φ <0.05 
SBNP thickness (μm) 10.05 ± 1.56 10.25 ± 2.98 11.08 ± 2.67 0.31 
Global reflectivity 0.29 ± 0.03 0.28 ± 0.04 0.29 ± 0.04 0.87 
Local reflectivity 0.32 ± 0.05 0.31 ± 0.06 0.32 ± 0.06 0.73 
Nerve reflectivity 0.75 ± 0.13 0.72 ± 0.12 0.77 ± 0.11 0.17 
Length (μm) 325.00 ± 87.12 308.54 ± 100.01 316.93 ± 84.59 0.57 
Width (μm) 3.64 ± 0.49 3.51 ± 0.77 3.62 ± 0.60 0.36 
Orientation (degrees) 90.71 ± 28.93 101.96 ± 37.25 100.70 ± 38.43 0.60 
Nerves (n) 4.30 ± 1.71 2.96 ± 1.23† 3.38 ± 1.47* <0.01 
ND (μm/mm2) 9624.21 ± 4896.21 6442.60 ± 3713.64† 7124.51 ± 3311.00* <0.01 
LCD (μm/mm2) 61.60 ± 36.32 64.48 ± 42.88 57.44 ± 33.76 0.24 
STC 1.44 ± 0.75 1.75 ± 0.65 1.59 ± 0.78 0.35 
OTC 19.74 ± 9.90 14.27 ± 6.66† 15.62 ± 9.23 <0.01 
 
Table 2. Variables recorded at baseline prior to OK treatment and changes produced in the central cornea after 1 
year of continuous OK treatment and 1 month after removing lenses. n number of right eyes of subjects/ number of 
items, m mean, SD standard deviation, cm centimeters, μm microns, mm2 squared millimeters, ND nerve density, 
LCD Langerhans cells density, STC subjective tortuosity coefficient, OTC objective tortuosity coefficient. (†) indicates 
significant differences between values at baseline and 1 year at p<0.01; (*) indicates significant differences between 
baseline and 1 month post-treatment at p<0.05; (φ) indicates significant differences between 1 year and 1 month 
post-treatment at p<0.05. 
 
  
 
TABLE 3 
MID-PERIPHERY  
(n = 32) 
 
BASELINE 
(m ± SD) 
 
TREATMENT 
1YEAR 
(m ± SD) 
 
1 MONTH POST-
TREATMENT 
(m ± SD) 
 
ANOVA 
p-value 
Corneal sensitivity (cm) 5.23 ± 0.66 5.36 ± 0.64 5.58 ± 0.36 0.07 
SBNP thickness (μm) 11.76 ± 4.12 9.83 ± 2.05 10.24 ± 2.51 0.07 
Global reflectivity 0.28 ± 0.03 0.29 ± 0.04 0.29 ± 0.03 0.71 
Local reflectivity 0.31 ± 0.04 0.31 ± 0.05 0.32 ± 0.05 0.86 
Nerve reflectivity 0.75 ± 0.11 0.73 ± 0.11 0.72 ± 0.13 0.32 
Length (μm) 332. 38 ± 93.93 327.51 ± 97.17 276.97 ± 92.78 0.40 
Width (μm) 3.60 ± 0.42 3.48 ± 0.60 3.61 ± 0.63 0.68 
Orientation (degrees) 95.32 ± 29.72 107.89 ± 42.95 102.02 ± 44.38 0.29 
Nerves (n) 4.66 ± 1.84 2.93 ± 1.59† 3.00 ± 1.59‡ <0.01 
ND (μm/mm2) 11056.25 ± 5918.35 6257.53 ± 4213.78† 6547.09 ± 4423.58‡ <0.01 
LCD (μm/mm2) 55.68 ± 36.16 76.32 ± 47.84 52.32 ± 41.76φ <0.05 
STC 1.38 ± 0.62 1.79 ± 0.96 1.53 ± 0.57 0.09 
OTC 20.21 ± 10.47 15.87 ± 8.94 15.26 ± 9.74* <0.05 
 
Table 3. Variables recorded at baseline prior to OK treatment and changes produced in the mid-peripheral cornea 
after 1 year of continuous OK treatment and 1 month after removing lenses. n number of right eyes of subjects/ 
number of items, m mean, SD standard deviation, cm centimeters, μm microns, mm2 squared millimeters, ND nerve 
density, LCD Langerhans cells density, STC subjective tortuosity coefficient, OTC objective tortuosity coefficient. (†) 
indicates significant differences between values at baseline and 1 year, p<0.01; (*) indicates significant differences 
between baseline and 1 month post-treatment at p<0.05; (‡) indicates significant differences between baseline and 1 
month post-treatment at p<0.01, (φ) indicates significant differences between 1 year and 1 month post-treatment at 
p<0.05. 
 
 
 
 
 
 
 
  
TABLE 4 
CONTROL GROUP  
(n = 15) 
 
BASELINE 
(m ± SD) 
 
Δ (1YEAR) 
(m ± SD) 
 
p-value 
Corneal sensitivity (cm) 4.90 ± 0.40 0.20 ± 0.27 0.18 
SBNP thickness (μm) 9.20 ± 1.79 -3.00 ± 3.05 0.09 
Global reflectivity 0.31 ± 0.02 0.01 ± 0.02 0.39 
Local reflectivity 0.30 ± 0.03 -0.01 ± 0.03 0.61 
Nerve reflectivity 0.69 ± 0.15 -0.03 ± 0.01 0.65 
Length (μm) 347.80 ± 60.66 68.00 ± 116.81 0.42 
Width (μm) 3.75 ± 0.28 -0.06 ± 0.21 0.55 
Orientation (degrees) 87.85 ± 30.83 -0.80 ± 4.44 0.71 
Nerves (n) 3.40 ± 0.64 -0.40 ± 1.52 0.59 
ND (μm/mm2) 10778.80 ± 3593.14 458,20 ± 1327,98 0.48 
LCD (μm/mm2) 19.60 ± 21.44 0.00 ± 0.71 0.91 
STC 2.40 ± 0.55 -0.20 ± 0.45 0.37 
OTC 17.24 ± 5.97 -2.60 ± 6.93 0.43 
 
Table 4. Parameter values for the control group and changes produced over 1 year. Positive values shown in the ∆ 
column correspond to a rise in the parameter value. n number of subjects/items, m mean, SD standard deviation, Δ 
difference between baseline and visit at 1 year, cm centimeters, μm microns, mm2 squared millimeters. 
re-reviewed figure 1a Click here to download Figure a_CentralSensitivity.tiff 
re-reviewed figure 1b Click here to download Figure b_CentralDensity.tiff 
re-reviewed figure 1c Click here to download Figure c_CentralOTC.tiff 
re-reviewed figure 1d Click here to download Figure d_MidperipheralLangerhans.tiff 
re-reviewed figure 1e Click here to download Figure e_MidperipheralDensity.tiff 
re-reviewed figure 1f Click here to download Figure f_MidperipheralOTC.tiff 
re-reviewed figure 1g legend Click here to download Figure g_Legend.tiff 
